Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03630198 · ClinicalTrials.gov registry record · Phase 4
Pain Outcomes Following Intralesional Corticosteroid Injections
A Phase 4 study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 31
- Enrollment target
NCT03630198 is a Phase 4 study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 31 participants.
The verdict
NCT03630198, a Phase 4 study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 31 participants
- Enrollment target
Study Summary
Corticosteroid therapy, including intralesional and topical applications, has many indications within the fields of Dermatology, Plastic Surgery, and Orthopedics. However, these injections can be quite painful, which leads many patients to discontinue treatment. Often, the injection involves a mixture of local anesthetic and corticosteroids despite a lack of evidence that the use of lidocaine improves pain. Due to the acidic pH, the lidocaine component of the injection can actually cause a significant burning sensation during the procedure. Lidocaine does not have anti-inflammatory properties and does not treat the underlying pathology. By including another medication, lidocaine also adds cost and risk to the procedure. The purpose of this study is to see if removing lidocaine from intralesional injections decreases the pain of injection.
Interventions
- DRUG Corticosteroid with normal saline
- DRUG Corticosteroid with lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2019-09-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03630198
The ClinicalTrials.gov registry entry for NCT03630198 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Corticosteroid with normal saline is the first listed.
NCT03630198 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03630198 about?
NCT03630198 is a clinical study titled "Pain Outcomes Following Intralesional Corticosteroid Injections". Corticosteroid therapy, including intralesional and topical applications, has many indications within the fields of Dermatology, Plastic Surgery, and Orthopedics. However, these injections can be quite painful, which leads many patients to discontinue treatment. Often, the injection involves a mixt...
What is the current status of trial NCT03630198?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 31 participants. The study started on 2018-10-01. Estimated completion is 2019-09-01.
What interventions are being tested in trial NCT03630198?
The interventions under investigation include: Corticosteroid with normal saline (DRUG), Corticosteroid with lidocaine (DRUG).
Who is sponsoring clinical trial NCT03630198?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.